Literature DB >> 34721714

KSNM60 in Clinical Nuclear Oncology.

Seung Hwan Moon1, Young Seok Cho1, Joon Young Choi1.   

Abstract

Since the foundation of the Korean Society of Nuclear Medicine in 1961, clinical nuclear oncology has been a major part of clinical nuclear medicine in Korea. There are several important events for the development of clinical nuclear oncology in Korea. First, a scintillating type gamma camera was adopted in 1969, which enabled to perform modern oncological gamma imaging. Second, Tc-99 m generator was imported to Korea since 1979, which promoted the wide clinical use of gamma camera imaging by using various kinds of Tc-99 m labeled radiopharmaceuticals. Third, a gamma camera with single photon emission tomography (SPECT) capability was first installed in 1980, which has been used for various kinds of tumor SPECT imaging. Fourth, in 1994, clinical positron emission tomography (PET) scanner and cyclotron with a production of F-18 fluorodeoxyglucose were first installed in Korea. Fifth, Korean Board of Nuclear Medicine was established in 1995, which contributed in the education and manpower training of dedicated nuclear medicine physicians in Korea. Finally, an integrated PET/CT scanner was first installed in 2002. Since that, PET/CT imaging has been a major imaging tool in clinical nuclear oncology in Korea. In this review, a brief history of clinical nuclear oncology in Korea is described. © Korean Society of Nuclear Medicine 2021.

Entities:  

Keywords:  Gamma camera; Korean Society of Nuclear Medicine; Nuclear oncology; PET; PET/CT; SPECT

Year:  2021        PMID: 34721714      PMCID: PMC8517057          DOI: 10.1007/s13139-021-00711-9

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  130 in total

1.  Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer.

Authors:  Jong-Ryool Oh; Ji-Hyoung Seo; Ari Chong; Jung-Joon Min; Ho-Chun Song; Young-Chul Kim; Hee-Seung Bom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-21       Impact factor: 9.236

2.  Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.

Authors:  Seok-Ki Kim; Hyuck Jae Choi; Sang-Yoon Park; Ho-Young Lee; Sang-Soo Seo; Chong Woo Yoo; Dae Chul Jung; Sokbom Kang; Kyung-Sik Cho
Journal:  Eur J Cancer       Date:  2009-05-04       Impact factor: 9.162

3.  Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer.

Authors:  Jeongmin Choi; Sang Gyun Kim; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  Surg Endosc       Date:  2009-12-24       Impact factor: 4.584

4.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Authors:  Sung Shine Shim; Kyung Soo Lee; Byung-Tae Kim; Myung Jin Chung; Eun Jung Lee; Joungho Han; Joon Young Choi; O Jung Kwon; Young Mog Shim; Seonwoo Kim
Journal:  Radiology       Date:  2005-07-12       Impact factor: 11.105

5.  Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET.

Authors:  Soon Yuhl Nam; Sang-wook Lee; Ki Chun Im; Jae-Seung Kim; Sang Yoon Kim; Seung-Ho Choi; Jin-Sook Ryu; Dae Hyuk Moon; Seung Joon Oh; Byong Yong Yi; Jong Hoon Kim; Seung Do Ahn; Seong Soo Shin; Sung-Bae Kim; Eun Kyung Choi; Bong-Jae Lee
Journal:  Oral Oncol       Date:  2005-04       Impact factor: 5.337

6.  Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.

Authors:  Yong-Il Kim; Jin Chul Paeng; Gi Jeong Cheon; Kyung-Suk Suh; Dong Soo Lee; June-Key Chung; Keon Wook Kang
Journal:  J Nucl Med       Date:  2016-03-16       Impact factor: 10.057

7.  The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.

Authors:  W H Choi; I R Yoo; J H O; S H Kim; S K Chung
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

8.  Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.

Authors:  June-Key Chung; Yu Kyeong Kim; Seok-ki Kim; Yong Jin Lee; Suntta Paek; Jeong Seok Yeo; Jae Min Jeong; Dong Soo Lee; Hee Won Jung; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-02       Impact factor: 9.236

9.  Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.

Authors:  Jeong Won Lee; Jin Kyoung Oh; Yong An Chung; Sae Jung Na; Seung Hyup Hyun; Il Ki Hong; Jae Seon Eo; Bong-Il Song; Tae-sung Kim; Do Young Kim; Seung Up Kim; Dae Hyuk Moon; Jong Doo Lee; Mijin Yun
Journal:  J Nucl Med       Date:  2016-01-07       Impact factor: 10.057

10.  Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.

Authors:  Seung Hyup Hyun; Jae Seon Eo; Jeong Won Lee; Joon Young Choi; Kyung-Han Lee; Sae Jung Na; Il Ki Hong; Jin Kyoung Oh; Yong An Chung; Bong-Il Song; Tae-Sung Kim; Kyung Sik Kim; Dae Hyuk Moon; Mijin Yun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-02       Impact factor: 9.236

View more
  1 in total

1.  Predicting the Recurrence of Gastric Cancer Using the Textural Features of Perigastric Adipose Tissue on [18F]FDG PET/CT.

Authors:  Hyein Ahn; Geum Jong Song; Si-Hyong Jang; Myoung Won Son; Hyun Ju Lee; Moon-Soo Lee; Ji-Hye Lee; Mee-Hye Oh; Geum Cheol Jeong; Jong Hyuk Yun; Sang Mi Lee; Jeong Won Lee
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.